Search

Author/Creator Anderton, Kate

1. ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial. Issue 5 (May 2018)

Authors:
Wrangle, John M; Velcheti, Vamsidhar; Patel, Manish R; Garrett-Mayer, Elizabeth; Hill, Elizabeth G; Ravenel, James G; Miller, Jeffrey S; Farhad, Mohammad; Anderton, Kate; Lindsey, Kathryn; Taffaro-Neskey, Michele; Sherman, Carol; Suriano, Samantha; Swiderska-Syn, Marzena; Sion, Amy; Harris, Joni;...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 5(2018)
Page Start:
694
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search